Therapixel Completes €15M Series B Financing to Deploy MammoScreen® 2D/3D
will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
Read Morewill accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
Read MoreAcquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio
Read MorePulsenmore’s handheld tele-ultrasound device docks with a smartphone, allowing women to perform ultrasound self-scans at home and receive fast clinical feedback from healthcare professionals
Read Morepotentially expanding the utility of AI to analyze tissues prepared with the most frequently used stain in histology
Read MoreThe funds will be used to commercialise its cardiology technology and commence the first-in-human clinical study of Ceryx’s cardiac rhythm management device, Cysoni, later this year
Read Morethe first FDA-authorized in vitro diagnostic test in the U.S. to aid in the assessment of Alzheimer’s disease and other causes of cognitive decline
Read Moredelivering unmatched performance and precision for both research and advanced clinical diagnostics
Read MoreGE Healthcare and RaySearch aim to enable hospitals and cancer treatment centers to implement an interoperable and integrated workflow that will optimize their clinical planning and operational outcomes
Read MoreRENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of overactive bladder (OAB)
Read MoreNext-generation Gamma Knife will enable more personalized radiosurgery with sub-millimeter accuracy and treatment planning in less than 60 seconds
Read More